High risk cutaneous squamous cell carcinoma of the head and neck
The majority of patients with head and neck cutaneous squamous cell carcinoma (cSCC) are successfully treated with surgical treatment of the primary site. While only a minority of patients is at risk for regional metastasis, these patients have significantly worse outcomes. Tumor and patient factors...
Saved in:
Main Authors: | Stephen Y. Kang, Amanda E. Toland |
---|---|
Format: | article |
Language: | EN |
Published: |
KeAi Communications Co., Ltd.
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/8312bec14a6c42198e11bbc7c4e0a448 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interleukin-6 role in head and neck squamous cell carcinoma progression
by: Moaz M. Choudhary, et al.
Published: (2016) -
Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
by: Christina Mimikos, et al.
Published: (2016) -
Predictors of occult lymph node metastasis in cutaneous head and neck melanoma
by: Jonathan S. Ni, et al.
Published: (2019) -
mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
by: Joseph D. Coppock, et al.
Published: (2016) -
Novel p53 therapies for head and neck cancer
by: Mario R. Castellanos, et al.
Published: (2016)